Skip to main content
Midas Edge

Passage BIO, Inc.

For the period ended Dec 31, 2025. Filed Mar 3, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 3, 2026

PASG$3.43-13.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Statements of Stockholders’ Equity

​​​​​​​​​​​​​​​​​​
​​​​​​​​​​​​​​​​​​
​​​​​​​​​​​​​​​​​​
​ · ​ · Common stock · ​ · ​ · Additional · ​ · ​ · Accumulated other · ​ · ​ · Accumulated · ​ · ​ · ​
(in thousands, except share data)​ ​ ​Shares​​Amount​​paid‑in capital​​comprehensive income (loss)​​ ​ ​deficit​​Total
Balance at January 1, 20242,805,618​$—​$705,794​$(43)​$(594,468)​$111,283
Issuance of common stock under the ATM Facility, net of offering costs​300,000​​—​​8,742​​—​​—​​8,742
Exercise of stock options and vesting of restricted stock units​45,649​​—​​35​​—​​—​​35
Issuance of shares in connection with employee stock purchase plan​10,236​​—​​97​​—​​—​​97
Unrealized gain (loss) on marketable securities​—​​—​—​​51​​—​​51
Share‑based compensation expense—​​—​​5,820​​—​​—​​5,820
Net loss—​​—​​—​​—​​(64,767)​​(64,767)
Balance at December 31, 20243,161,503​$—​$720,488​$8​$(659,235)​$61,261
​​​​​​​​​​​​​​​​​​
​​​​​​​​​​​​​​​​​​
​ · ​ · Common stock · ​ · ​ · Additional · ​ · ​ · Accumulated other · ​ · ​ · Accumulated · ​ · ​ · ​
(in thousands, except share data)​ ​ ​Shares​ ​ ​​Amount​ ​ ​​ ​ ​paid‑in capital​​comprehensive income (loss)​​ ​ ​deficit​​Total
Balance at January 1, 20253,161,503​$—​$720,488​$8​$(659,235)​$61,261
Exercise of stock options and vesting of restricted stock units16,825​—​—​—​—​—
Issuance of shares in connection with employee stock purchase plan​4,482​​—​​23​​—​​—​​23
Unrealized gain (loss) on marketable securities—​—​—​(8)​—​(8)
Share‑based compensation expense—​—​3,001​—​—​3,001
Net loss—​—​—​—​(45,522)​(45,522)
Balance at December 31, 20253,182,810​$—​$723,512​$—​$(704,757)​$18,755
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.